Koh-ichi Wada Selected Research

Arginine Vasopressin (Argipressin)

1/2007	A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
2/2003	Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koh-ichi Wada Research Topics

Disease

2	Myocardial Infarction 01/2005 - 08/2002
2	Heart Failure 01/2005 - 08/2002
1	Hyponatremia 01/2007
1	Inappropriate ADH Syndrome (SIADH) 01/2007
1	Coronary Occlusion 01/2005
1	Body Weight (Weight, Body) 01/2005
1	Hypertension (High Blood Pressure) 02/2003
1	Hypertrophy 10/2002
1	Hyperplasia 10/2002

Drug/Important Bio-Agent (IBA)

3	Vasopressins (Vasopressin)IBA 01/2007 - 08/2002
3	conivaptan (Vaprisol)FDA Link 01/2007 - 08/2002
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2007 - 01/2005
2	Arginine Vasopressin (Argipressin)IBA 01/2007 - 02/2003
1	Furosemide (Lasix)FDA LinkGeneric 01/2007
1	ElectrolytesIBA 01/2007
1	SodiumIBA 01/2007
1	salicylhydroxamic acid (SHAM)IBA 01/2005
1	4'- (4,4- difluoro- 5- (2- (4- dimethylaminopiperidino)- 2- oxoethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- phenylbenzanilideIBA 10/2002
1	Antidiuretic Hormone Receptor AntagonistsIBA 08/2002

Therapy/Procedure

2	Intravenous Administration 01/2007 - 01/2005
1	Oral Administration 08/2002